(NTES) NetEase - Overview
Exchange: NASDAQ •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US64110W1027
Stock: Games, Music, Learning, Content, Devices
Total Rating 39
Risk 75
Buy Signal -0.64
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -12.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | 6.14 |
| Character TTM | |
|---|---|
| Beta | 0.508 |
| Beta Downside | -0.110 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.97% |
| CAGR/Max DD | 0.37 |
EPS (Earnings per Share)
Revenue
Description: NTES NetEase February 27, 2026
NetEase, Inc. (NASDAQ: NTES) operates four core segments: Games and Related Value-Added Services, Youdao (online intelligent learning), NetEase Cloud Music, and a portfolio of Innovative Businesses that includes AI-driven education tools, smart devices, and online marketing services.
In the latest quarter (Q3 2025), the company reported revenue of $2.48 billion, up 12% year-over-year, with gaming contributing roughly 60% of total sales. Cloud Music’s monthly active users surpassed 600 million, while Youdao’s AI-enhanced education products drove a 35% jump in segment revenue, reflecting strong demand for digital learning solutions in China.
Key drivers include the recent relaxation of Chinese gaming regulations, accelerating the launch of new titles, and the broader adoption of generative AI in education, which is expanding Youdao’s addressable market. Additionally, rising consumer disposable income and increased mobile internet penetration continue to boost streaming and online services demand.
For a deeper quantitative analysis, you may want to explore ValueRay’s detailed metrics on NTES.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 33.67b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 2.72 > 1.0 |
| NWC/Revenue: 114.3% < 20% (prev 98.44%; Δ 15.88% < -1%) |
| CFO/TA 0.23 > 3% & CFO 50.39b > Net Income 33.67b |
| Net Debt (-45.13b) to EBITDA (37.96b): -1.19 < 3 |
| Current Ratio: 3.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (645.6m) vs 12m ago 0.68% < -2% |
| Gross Margin: 64.29% > 18% (prev 0.62%; Δ 6366 % > 0.5%) |
| Asset Turnover: 53.76% > 50% (prev 53.72%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: -7.14 > 6 (EBITDA TTM 37.96b / Interest Expense TTM -5.01b) |
Altman Z''
| A: 0.58 (Total Current Assets 180.73b - Total Current Liabilities 52.40b) / Total Assets 221.56b |
| B: error (Retained Earnings missing) |
| C: 0.17 (EBIT TTM 35.72b / Avg Total Assets 208.77b) |
| D: 2.85 (Book Value of Equity 160.40b / Total Liabilities 56.35b) |
Beneish M -3.27
| DSRI: 0.88 (Receivables 5.34b/5.67b, Revenue 112.25b/105.30b) |
| GMI: 0.97 (GM 64.29% / 62.50%) |
| AQI: 0.84 (AQ_t 0.15 / AQ_t-1 0.17) |
| SGI: 1.07 (Revenue 112.25b / 105.30b) |
| TATA: -0.08 (NI 33.67b - CFO 50.39b) / TA 221.56b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of NTES shares?
As of March 04, 2026, the stock is trading at USD 115.19 with a total of 951,282 shares traded.
Over the past week, the price has changed by -0.98%, over one month by -10.76%, over three months by -18.72% and over the past year by +22.31%.
Over the past week, the price has changed by -0.98%, over one month by -10.76%, over three months by -18.72% and over the past year by +22.31%.
Is NTES a buy, sell or hold?
NetEase has received a consensus analysts rating of 4.65.
Therefore, it is recommended to buy NTES.
- StrongBuy: 22
- Buy: 7
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NTES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 164.4 | 42.7% |
| Analysts Target Price | 164.4 | 42.7% |
NTES Fundamental Data Overview February 28, 2026
P/E Trailing = 15.1298
P/E Forward = 16.0
P/S = 0.6593
P/B = 4.6182
P/EG = 1.215
Revenue TTM = 112.25b USD
EBIT TTM = 35.72b USD
EBITDA TTM = 37.96b USD
Long Term Debt = unknown (0.0)
Short Term Debt = 6.39b USD (from shortTermDebt, last quarter)
Debt = 6.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -45.13b USD (from netDebt column, last quarter)
Enterprise Value = -86.40b USD (74.25b + Debt 6.39b - CCE 167.04b)
Interest Coverage Ratio = -7.14 (Ebit TTM 35.72b / Interest Expense TTM -5.01b)
EV/FCF = -1.78x (Enterprise Value -86.40b / FCF TTM 48.52b)
FCF Yield = -56.16% (FCF TTM 48.52b / Enterprise Value -86.40b)
FCF Margin = 43.23% (FCF TTM 48.52b / Revenue TTM 112.25b)
Net Margin = 30.00% (Net Income TTM 33.67b / Revenue TTM 112.25b)
Gross Margin = 64.29% ((Revenue TTM 112.25b - Cost of Revenue TTM 40.09b) / Revenue TTM)
Gross Margin QoQ = 64.23% (prev 64.10%)
Tobins Q-Ratio = -0.39 (set to none) (Enterprise Value -86.40b / Total Assets 221.56b)
Interest Expense / Debt = 9.85% (Interest Expense 629.3m / Debt 6.39b)
Taxrate = 16.41% (1.23b / 7.52b)
NOPAT = 29.86b (EBIT 35.72b * (1 - 16.41%))
Current Ratio = 3.45 (Total Current Assets 180.73b / Total Current Liabilities 52.40b)
Debt / Equity = 0.04 (Debt 6.39b / totalStockholderEquity, last quarter 160.40b)
Debt / EBITDA = -1.19 (Net Debt -45.13b / EBITDA 37.96b)
Debt / FCF = -0.93 (Net Debt -45.13b / FCF TTM 48.52b)
Total Stockholder Equity = 152.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.13% (Net Income 33.67b / Total Assets 221.56b)
RoE = 22.08% (Net Income TTM 33.67b / Total Stockholder Equity 152.52b)
RoCE = 23.42% (EBIT 35.72b / Capital Employed (Equity 152.52b + L.T.Debt 0.0))
RoIC = 18.73% (NOPAT 29.86b / Invested Capital 159.38b)
WACC = 7.83% (E(74.25b)/V(80.64b) * Re(7.79%) + D(6.39b)/V(80.64b) * Rd(9.85%) * (1-Tc(0.16)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.33%
[DCF] Terminal Value 81.83% ; FCFF base≈44.15b ; Y1≈54.46b ; Y5≈92.75b
[DCF] Fair Price = 2637 (EV 1624.83b - Net Debt -45.13b = Equity 1669.96b / Shares 633.2m; r=7.83% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 69.13 | EPS CAGR: 9.84% | SUE: -2.12 | # QB: 0
Revenue Correlation: 84.66 | Revenue CAGR: 3.88% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-06-30): EPS=15.04 | Chg7d=-0.086 | Chg30d=-0.201 | Revisions Net=-1 | Analysts=7
EPS current Year (2026-12-31): EPS=63.23 | Chg7d=-0.102 | Chg30d=-2.031 | Revisions Net=-19 | Growth EPS=+9.0% | Growth Revenue=+7.6%
EPS next Year (2027-12-31): EPS=69.92 | Chg7d=-0.112 | Chg30d=-2.099 | Revisions Net=-11 | Growth EPS=+10.6% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.3% (Discount Rate 7.9% - Earnings Yield 6.6%)
[Growth] Growth Spread = +4.2% (Analyst 5.5% - Implied 1.3%)
P/E Forward = 16.0
P/S = 0.6593
P/B = 4.6182
P/EG = 1.215
Revenue TTM = 112.25b USD
EBIT TTM = 35.72b USD
EBITDA TTM = 37.96b USD
Long Term Debt = unknown (0.0)
Short Term Debt = 6.39b USD (from shortTermDebt, last quarter)
Debt = 6.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -45.13b USD (from netDebt column, last quarter)
Enterprise Value = -86.40b USD (74.25b + Debt 6.39b - CCE 167.04b)
Interest Coverage Ratio = -7.14 (Ebit TTM 35.72b / Interest Expense TTM -5.01b)
EV/FCF = -1.78x (Enterprise Value -86.40b / FCF TTM 48.52b)
FCF Yield = -56.16% (FCF TTM 48.52b / Enterprise Value -86.40b)
FCF Margin = 43.23% (FCF TTM 48.52b / Revenue TTM 112.25b)
Net Margin = 30.00% (Net Income TTM 33.67b / Revenue TTM 112.25b)
Gross Margin = 64.29% ((Revenue TTM 112.25b - Cost of Revenue TTM 40.09b) / Revenue TTM)
Gross Margin QoQ = 64.23% (prev 64.10%)
Tobins Q-Ratio = -0.39 (set to none) (Enterprise Value -86.40b / Total Assets 221.56b)
Interest Expense / Debt = 9.85% (Interest Expense 629.3m / Debt 6.39b)
Taxrate = 16.41% (1.23b / 7.52b)
NOPAT = 29.86b (EBIT 35.72b * (1 - 16.41%))
Current Ratio = 3.45 (Total Current Assets 180.73b / Total Current Liabilities 52.40b)
Debt / Equity = 0.04 (Debt 6.39b / totalStockholderEquity, last quarter 160.40b)
Debt / EBITDA = -1.19 (Net Debt -45.13b / EBITDA 37.96b)
Debt / FCF = -0.93 (Net Debt -45.13b / FCF TTM 48.52b)
Total Stockholder Equity = 152.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.13% (Net Income 33.67b / Total Assets 221.56b)
RoE = 22.08% (Net Income TTM 33.67b / Total Stockholder Equity 152.52b)
RoCE = 23.42% (EBIT 35.72b / Capital Employed (Equity 152.52b + L.T.Debt 0.0))
RoIC = 18.73% (NOPAT 29.86b / Invested Capital 159.38b)
WACC = 7.83% (E(74.25b)/V(80.64b) * Re(7.79%) + D(6.39b)/V(80.64b) * Rd(9.85%) * (1-Tc(0.16)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.33%
[DCF] Terminal Value 81.83% ; FCFF base≈44.15b ; Y1≈54.46b ; Y5≈92.75b
[DCF] Fair Price = 2637 (EV 1624.83b - Net Debt -45.13b = Equity 1669.96b / Shares 633.2m; r=7.83% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 69.13 | EPS CAGR: 9.84% | SUE: -2.12 | # QB: 0
Revenue Correlation: 84.66 | Revenue CAGR: 3.88% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-06-30): EPS=15.04 | Chg7d=-0.086 | Chg30d=-0.201 | Revisions Net=-1 | Analysts=7
EPS current Year (2026-12-31): EPS=63.23 | Chg7d=-0.102 | Chg30d=-2.031 | Revisions Net=-19 | Growth EPS=+9.0% | Growth Revenue=+7.6%
EPS next Year (2027-12-31): EPS=69.92 | Chg7d=-0.112 | Chg30d=-2.099 | Revisions Net=-11 | Growth EPS=+10.6% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.3% (Discount Rate 7.9% - Earnings Yield 6.6%)
[Growth] Growth Spread = +4.2% (Analyst 5.5% - Implied 1.3%)